Breast cancer due to the unpredictable and complex etiopathology combined with the non-
availability of any effective drug treatment has become the major root of concern for …

Triple-negative breast cancer is considered the most aggressive type of breast cancer
among women and the lack of expressed receptors has made treatment options …

Cancer nanomedicines and the development of state-of-the-art multifunctional lipid-based
nanoparticles (NPs) has become a fundamental resource in resolving challenging …

Globally, breast cancer is one of the most prevalent diseases, inducing critical intimidation to
human health. Lipid-based nanomaterials have been successfully demonstrated as drug …

One of the most common cancers that occur in females is breast cancer. Despite the
significant leaps and bounds that have been made in treatment of breast cancer, the disease …

Lipid nanoparticles (LNPs), composed of ionized lipids, helper lipids, and cholesterol,
provide general therapeutic effects by facilitating intracellular transport and avoiding …

Breast cancer is the second leading cancer-related disease as the most common non-
cutaneous malignancy among women. Curative options for breast cancer are limited …

Breast cancer (BC) is the most extensively accounted malignancy among the women across
the globe and is treatable in 70–80% of patients with early-stage, non-metastatic cancer …

Breast cancer is one of the leading types among the common non-cutaneous malignancies
in women. All the curative methods available for its treatment are minimal due to their toxicity …

Breast cancer is the most common type of cancer with the highest morbidity and mortality
rates in women worldwide. Recent efforts to improve the current antitumor therapies have …